Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
March 02, 2021 08:05 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Tissue Engineering and Vascularization 2020: Current and Emerging Applications of Artificial Vasculature
October 20, 2020 12:28 ET
|
Research and Markets
Dublin, Oct. 20, 2020 (GLOBE NEWSWIRE) -- The "Artificial Vasculature and Micro-Environmental Factors Supporting Tissue Engineering and Organoids" report has been added to ResearchAndMarkets.com's...
Organovo to Explore Strategic Alternatives and Implement Restructuring Plan
August 07, 2019 09:00 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it has engaged Roth Capital Partners (“Roth”) as its financial advisor to assist...
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
July 18, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
July 08, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo to Present at Raymond James Life Sciences and MedTech Conference
June 13, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
May 30, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results
May 22, 2019 16:05 ET
|
Organovo, Inc.
- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings,...
Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean
April 17, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a...
Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference
March 14, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31st Annual ROTH Conference, being held...